Please assess the completion status of the following clinical trial:

Trial Title: High Amylose Maize Starch for Treatment of Cholera

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: None
- Number of Arms: None

Eligibility Criteria:
INCLUSION CRITERIA:~A participant is considered eligible for participation in the trial if the following inclusion criteria are satisfied on admission (Day 1, before randomization) to the hospital:~1. Participant is a male between 18 and 65 years of age inclusive~2. Severe watery diarrhea without fecal blood of less than 48 hours (with passage of 3 or more watery stools in the 24 hours before admission)~3. Signs of severe dehydration as per ICDDR,B guidelines (modified WHO guideline)~4. Dipstick test/Dark-field examination positive for Vibrio cholera~5. Written informed consent is provided~6. Participant is willing and able to comply with all trial requirements~EXCLUSION CRITERIA:~A participant who meets any of the following criteria on admission (before randomization) to the hospital will not qualify for the study~1. Evidence or history of any clinically significant illness as per the Investigator's discretion.~2. Known case of HIV or Hepatitis B~3. History of cancer~4. Known renal disease~5. Frequent excessive alcohol use, binge drinking (e.g. men consume 5 or more drinks in about 2 hours) or use of illicit drugs within the past two years~6. History of receiving antimicrobial or anti-diarrheal medication (loperamide, diphenoxylate, etc.) within seven days of admission~7. Concomitant infection requiring antimicrobial therapy~8. Donated blood or plasma or experienced clinically significant loss of blood within eight weeks prior to admission or who plan to donate blood within 1 month after study participation~9. Clinically significant abnormal laboratory test results as determined by the investigator~10. Treatment within 30 days prior to admission (or five half-lives of the compound, if longer) with any investigational agent or device~11. History of seizure (including febrile seizure) or loss of consciousness;~12. History of any GI Surgery related to Bowel resections and gastric anastomoses in past except Appendicitis~13. For any reason, deemed by the investigator to be inappropriate for this study, including participants who are unable to communicate or to cooperate with the investigator or designee~14. Prior enrolment in this trial

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Males (Type: None): Adult 18-65

Based on this trial design, predict the completion outcome and termination type (if applicable).